Fulton Bank’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.17M | Buy |
20,218
+251
| +1% | +$27K | 0.08% | 176 |
|
2025
Q1 | $2.01M | Sell |
19,967
-3,544
| -15% | -$358K | 0.08% | 176 |
|
2024
Q4 | $2.1M | Sell |
23,511
-317
| -1% | -$28.3K | 0.08% | 178 |
|
2024
Q3 | $2M | Sell |
23,828
-314
| -1% | -$26.3K | 0.08% | 181 |
|
2024
Q2 | $1.86M | Sell |
24,142
-1,487
| -6% | -$115K | 0.08% | 182 |
|
2024
Q1 | $1.76M | Sell |
25,629
-18
| -0.1% | -$1.23K | 0.07% | 200 |
|
2023
Q4 | $1.48M | Buy |
25,647
+236
| +0.9% | +$13.6K | 0.07% | 214 |
|
2023
Q3 | $1.34M | Sell |
25,411
-309
| -1% | -$16.3K | 0.07% | 210 |
|
2023
Q2 | $1.39M | Sell |
25,720
-4,339
| -14% | -$235K | 0.07% | 207 |
|
2023
Q1 | $1.5M | Sell |
30,059
-1,028
| -3% | -$51.4K | 0.08% | 191 |
|
2022
Q4 | $1.44M | Sell |
31,087
-1,168
| -4% | -$54K | 0.08% | 185 |
|
2022
Q3 | $1.25M | Sell |
32,255
-221
| -0.7% | -$8.56K | 0.07% | 195 |
|
2022
Q2 | $1.21M | Sell |
32,476
-380
| -1% | -$14.2K | 0.07% | 196 |
|
2022
Q1 | $1.46M | Sell |
32,856
-2,678
| -8% | -$119K | 0.07% | 193 |
|
2021
Q4 | $1.51M | Sell |
35,534
-1,408
| -4% | -$59.8K | 0.07% | 201 |
|
2021
Q3 | $1.6M | Buy |
36,942
+34
| +0.1% | +$1.48K | 0.07% | 180 |
|
2021
Q2 | $1.58M | Sell |
36,908
-1,148
| -3% | -$49.1K | 0.07% | 176 |
|
2021
Q1 | $1.47M | Sell |
38,056
-2,995
| -7% | -$116K | 0.07% | 184 |
|
2020
Q4 | $1.48M | Buy |
41,051
+2,149
| +6% | +$77.3K | 0.08% | 174 |
|
2020
Q3 | $1.49M | Sell |
38,902
-1,406
| -3% | -$53.7K | 0.09% | 158 |
|
2020
Q2 | $1.42M | Buy |
+40,308
| New | +$1.42M | 0.09% | 162 |
|